Omega Healthcare Investors (OHI) RevCDI Scores 97.8 in KLAS, Boosts Ambulatory Documentation Quality
- Omega’s RevCDI earned a KLAS First Look score of 97.8/100 and five A+ grades.
- RevCDI, part of Omega Digital Platform, pairs AI feedback with clinician‑led CDI and integrates to reduce denials.
- 100% of Omega customers would repurchase RevCDI and report measurable ROI within six months.
Boca Raton Firm’s RevCDI Draws Industry Acclaim
Omega Healthcare Investors’ RevCDI solution earns a near‑perfect performance rating in a new KLAS First Look report, underscoring the company’s push into AI‑enabled clinical documentation improvement for ambulatory care. The KLAS report “Omega Healthcare RevCDI 2026: Improving Ambulatory Documentation Quality, Integrity & Efficiency” gives RevCDI an overall score of 97.8 out of 100 and five A+ grades, citing rapid support, measurable outcomes and strong customer loyalty. RevCDI is marketed as part of Omega’s broader Omega Digital Platform (ODP) and pairs an AI‑enabled feedback loop with clinician‑led documentation guidance.
KLAS highlights early‑use learnings from ambulatory practices of varying sizes, reporting streamlined workflows, faster coder alignment and fewer documentation errors where RevCDI is deployed. The platform embeds a SaaS feedback mechanism into provider workflow while routing complex cases to specialized clinical documentation improvement (CDI) teams, which include RNs with CDI credentials and clinicians with coding and HIM expertise. Within ODP, RevCDI is presented as able to integrate with Omega’s other technologies to support work RVUs and reduce denials without delaying claims submission or adding burdens on providers.
Customer responses in the KLAS assessment are uniformly positive: 100% of respondents say they would buy RevCDI again and all report measurable outcomes and ROI within six months of use. KLAS and Omega report documented benefits across multiple specialties, including faster claim processing, improved documentation integrity and demonstrable financial gains, which the vendor says validate the solution’s scalability and value in ambulatory settings. Omega’s leadership stresses the product’s hybrid model as a way to accelerate provider learning while protecting compliance and reporting standards.
Clinical Workflow and Compliance Gains
KLAS notes consistent improvements in compliance metrics and coder alignment among early adopters, with clients reporting reduced documentation errors and administrative burden. The combination of automated feedback and human review helps ensure records meet regulatory requirements and supports timely, coder‑aligned claims.
Leadership Response and Market Positioning
CEO and co‑founder Anurag Mehta frames the A+ grades as evidence of loyalty, quality and value, emphasizing ambulatory ROI for professional fee claims. Chief Medical Officer Dave Friedenson highlights that clinically accurate, coder‑aligned guidance reduces physician burnout and empowers clinical staff, positioning RevCDI as a technology‑plus‑human solution aimed at improving documentation quality and operational efficiency.